| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Biological and Medical Research, Argonne National Laboratory, Argonne, Illinois 60439
Earlier studies showed that phenobarbital feeding enhanced hepatic tumorigenesis in rats previously fed 2-acetylaminofluorene for a brief period. As part of an investigation of the mechanism of this enhancement, the present study evaluated the relative enhancing abilities of amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane (DDT), agents that resemble phenobarbital to varying degrees in their effects on liver structure and metabolism. A comparison of hepatic tumor yields in rats fed 2-acetylaminofluorene, followed by the test substance (sequential treatment), showed that amobarbital and diphenylhydantoin had no enhancing activity, whereas the enhancing effect of DDT was similar to that of phenobarbital. These results show that the sequential treatment technique readily distinguishes among substances differing in enhancing ability and should prove useful in screening additional substances for this activity. The comparative biochemical effects of these substances in the liver can then be correlated with their relative enhancing abilities to provide information on the molecular events specifically associated with enhancement. Such correlations were initiated in this study by comparing the effects of the four test substances on liver weight and DNA synthesis. The results showed that the enhancers, phenobarbital and DDT, each stimulated liver DNA synthesis and increased liver weight, whereas the nonenhancers, amobarbital and diphenylhydantoin, had neither effect.
Phenobarbital and DDT both increased the early tumor incidence rate and maintained an increment in tumor incidence over that in the other treatment groups throughout the experiment, although it is not clear whether this increment would persist indefinitely. In addition, although the spectrum of tumor types observed ranged from highly differentiated to poorly differentiated in all treatment groups, DDT and phenobarbital selectively increased the incidence of highly differentiated tumors throughout most of the experiment.
1 This work was supported by the United States Energy Research and Development Administration.
2 Doctoral candidate in the General Sciences Department, Oregon State University, Corvallis, Ore. 97331.
Received 3/27/75. Accepted 7/ 9/75.
This article has been cited by other articles:
|
|
 |
|
  N.J. Hodges, T.C. Orton, A.J. Strain, and J.K. Chipman Potentiation of epidermal growth factor-induced DNA synthesis in rat hepatocytes by phenobarbitone: possible involvement of oxidative stress and kinase activation Carcinogenesis, November 1, 2000; 21(11): 2041 - 2047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Haag-Gronlund, R. Conolly, G. Scheu, L. Warngard, and R. Fransson-Steen Analysis of Rat Liver Foci Growth with a Quantitative Two-Cell Model after Treatment with 2,4,5,3',4'-Pentachlorobiphenyl Toxicol. Sci., September 1, 2000; 57(1): 32 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shoda, K. Mitsumori, H. Onodera, K. Toyoda, C. Uneyama, K. Takada, and M. Hirose Live Tumor-Promoting Effect of {beta}-Naphthoflavone, a Strong CYP 1A1/2 Inducer, and the Relationship between CYP 1A1/2 Induction and Cx32 Decrease in Its Hepatocarcinogenesis in the Rat Toxicol Pathol, July 1, 2000; 28(4): 540 - 547. [Abstract] [PDF]
|
|
|
|
|
|
T. Shoda, H. Onodera, M. Takeda, C. Uneyama, T. Imazawa, K. Takegawa, K. Yasuhara, T. Watanabe, M. Hirose, and K. Mitsumori Liver Tumor Promoting Effects of Fenbendazole in Rats Toxicol Pathol, September 1, 1999; 27(5): 553 - 562. [Abstract] [PDF]
|
|
|
|
|
|
R. A. Roberts and I. Kimber Cytokines in non-genotoxic hepatocarcinogenesis Carcinogenesis, August 1, 1999; 20(8): 1397 - 1402. [Full Text] [PDF]
|
|
|
|
|
|
S. Sanders and S. S. Thorgeirsson Phenobarbital promotes liver growth in c-myc/TGF-{alpha} transgenic mice by inducing hypertrophy and inhibiting apoptosis Carcinogenesis, January 1, 1999; 20(1): 41 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Moser, D. C. Wolf, and T. L. Goldsworthy Quantitative Relationship Between Transforming Growth Factor-Alpha and Hepatic Focal Phenotype and Progression in Female Mouse Liver Toxicol Pathol, May 1, 1997; 25(3): 275 - 283. [Abstract] [PDF]
|
|
|
|
 |
|
 L. A Dethloff, M. J Graziano, E. Goldenthal, A. Gough, and F. A de la Iglesia Perspective on the carcinogenic potential of phenytoin based on rodent tumor bioassays and human epidemiological data Human and Experimental Toxicology, April 1, 1996; 15(4): 335 - 348. [Abstract] [PDF]
|
|
|
|
 |
|
 J. S. Sidhu and C. J. Omiecinski cAMP-associated Inhibition of Phenobarbital-inducible Cytochrome P450 Gene Expression in Primary Rat Hepatocyte Cultures J. Biol. Chem., May 26, 1995; 270(21): 12762 - 12773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Lubet, R. W. Nims, J. M. Ward, J. M. Rice, and B. A. Diwan Induction of Cytochrome P450b and Its Relationship to Liver Tumor Promotion International Journal of Toxicology, March 1, 1989; 8(2): 259 - 268. [Abstract] [PDF]
|
|
|
|
 |
|
 R. S. Schoeny and E. Margosches Evaluating Comparative Potencies: Developing Approaches To Risk Assessment of Chemical Mixtures Toxicology and Industrial Health, January 1, 1989; 5(5): 825 - 837. [Abstract] [PDF]
|
|
|
|
|
|
A.E.M. McLean Is Enzyme Induction Good for You? A Problem of Epidemiology and Toxicology Human and Experimental Toxicology, September 1, 1988; 7(5): 419 - 422. [Abstract] [PDF]
|
|
|
|
|
|
J. E. Klaunig, M. A. Pereira, R. J. Ruch, and C. M. Weghorst Dose-Response Relationship of Diethylnitrosamine-Initiated Tumors in Neonatal Balb/c Mice: Effect of Phenobarbital Promotion Toxicol Pathol, April 1, 1988; 16(3): 381 - 385. [Abstract] [PDF]
|
|
|
|
|
|
S. Parodi, P. Boero, M. Taningher, P. Storace, and L. Santi Utilization of the Quantitative Component of the Information Obtained from Short Term Tests Toxicol Pathol, February 1, 1987; 15(2): 206 - 212. [Abstract] [PDF]
|
|
|
|
|
|
T. Kitagawa Promoting and Anticarcinogenic Effects of Phenobarbital and DDT in the Rat Hepatocarcinogenesis Toxicol Pathol, April 1, 1986; 14(3): 309 - 314. [Abstract] [PDF]
|
|
|
|
|
|
K. C. Cater, A. J. Gandolfi, and I. G. Sipes Characterization of Dimethylnitrosamineinduced Focal and Nodular Lesions in the Livers of Newborn Mice Toxicol Pathol, January 1, 1985; 13(1): 3 - 9. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Pereira Mouse Liver Tumor Data: Assessment of Carcinogenic Activity Toxicology and Industrial Health, January 1, 1985; 1(4): 311 - 333. [Abstract] [PDF]
|
|
|
|
|
|
G. M. Williams Phenotypic Properties of Preneoplastic Rat Liver Lesions and Applications to Detection of Carcinogens and Tumor Promoters Toxicol Pathol, February 1, 1982; 10(2): 3 - 10. [Abstract] [PDF]
|
|
|
|
|
|
R. Schulte-Hermann, I. Timmermann-Trosiener, and J. Schuppler Response of liver foci in rats to hepatic tumor promoters Toxicol Pathol, February 1, 1982; 10(2): 63 - 68. [Abstract] [PDF]
|
|
|
|
|
|
P. M. Newberne, J. L. V. de Camargo, and A. J. Clark Choline Deficiency, Partial Hepatectomy, and Liver Tumors in Rats and Mice Toxicol Pathol, February 1, 1982; 10(2): 95 - 106. [Abstract] [PDF]
|
|
|
|
|
|
General discussion Toxicol Pathol, February 1, 1982; 10(2): 106 - 109. [PDF]
|
|
|
|
|
|
J. Schuppler, R. Schulte-Hermann, I. Timmermann-Trosiener, and P. Gunzel Proliferative liver lesions and sex steroids in rats Toxicol Pathol, February 1, 1982; 10(2): 132 - 143. [Abstract] [PDF]
|
|
|
|
|
|
Liver Lesions from Sex Steroids Toxicol Pathol, February 1, 1982; 10(2): 143 - 144. [PDF]
|
|
|
|
|
|
B. M. Sparano, M. P. Brecher, G. Gordon, M. J. Iatropoulos, C. D. King, and P. Gallo Chemically Induced Hepatocellular Proliferative Changes in the Rat Without Evidence of Neoplastic Transformation Toxicol Pathol, February 1, 1982; 10(2): 175 - 187. [Abstract] [PDF]
|
|
|
|
|
|
Hepatoproliferativ Changes in Rats Toxicol Pathol, February 1, 1982; 10(2): 187 - 189. [PDF]
|
|
|
|
|
|
B. L. V. Duuren Cocarcinogens and Tumor Promoters and Their Environmental Importance International Journal of Toxicology, January 1, 1982; 1(1): 17 - 27. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Pereira Rat Liver Foci Bioassay International Journal of Toxicology, January 1, 1982; 1(1): 101 - 117. [Abstract] [PDF]
|
|
|
|
|
|
S. Goldfarb and T. D. Pugh The Origin and Significance of Hyperplastic Hepatocellular Islands and Nodules in Hepatic Carcinogenesis International Journal of Toxicology, January 1, 1982; 1(1): 119 - 144. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Yotti, C. Chang, and J. Trosko Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter Science, November 30, 1979; 206(4422): 1089 - 1091. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
